Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|November 24, 2017
HER2 expression patterns in paired primary and metastatic endometrial cancer lesionsMari Kyllesø Halle, Ingvild Løberg Tangen, Hege Fredriksen Berg, et al.
Scientific Reports|September 2, 2017
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancerSiv Mjos, Henrica M J Werner, Even Birkeland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
<i>PIK3CA</i> Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial CarcinomaFrederik Holst, Henrica M J Werner, Siv Mjøs, et al.
Oncotarget|October 6, 2017
Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancersAnna Berg, Ankush Gulati, Sigmund Ytre-Hauge, et al.
Oncotarget|November 22, 2014
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patientsAnna Berg, Erling A Hoivik, Siv Mjøs, et al.
Plos One|February 9, 2013
Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancersMaria B Raeder, Even Birkeland, Jone Trovik, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2016
Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial CancerTarjei S Hveem, Tormund S Njølstad, Birgitte Nielsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2008
Drug-sensitive FGFR2 mutations in endometrial carcinomaAmit Dutt, Helga B Salvesen, Tzu-Hsiu Chen, et al.
British Journal of Cancer|August 10, 2016
L1CAM expression in endometrial carcinomas: an ENITEC collaboration studyLouis Jm van der Putten, Nicole Cm Visser, Koen van de Vijver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2017
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group InitiativeTine Cuppens, Daniela Annibali, An Coosemans, et al.
Pageof 14